Monilola A. Olayioye
Stuttgart, BW 70174, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Novel bispecific T-cell engagers overcoming acquired EGFR resistance.
Journal: mAbs
Published: May 19, 2026
Filamin a binds deleted in liver cancer 1 (DLC1) to promote its tumor suppressor activity and inhibit the SRF coactivator MRTF-A.
Journal: Neoplasia (New York, N.Y.)
Published: September 19, 2025
BCL-xL as a therapeutic target in cetuximab-refractory colorectal cancer.
Journal: Cell death & disease
Published: June 30, 2025
Trispecific eFab-eIg T-cell engagers targeting HER2 and HER3.
Journal: Frontiers in immunology
Published: June 06, 2025
PHF19 drives the formation of PRC2 clusters to enhance motility in TNBC cells.
Journal: Cell reports
Published: April 06, 2025
Integrated mathematical and experimental modeling uncovers enhanced EMT plasticity upon loss of the DLC1 tumor suppressor.
Journal: PLoS computational biology
Published: September 19, 2024
Regulation and functions of the DLC family of RhoGAP proteins: Implications for development and cancer.
Journal: Cellular signalling
Published: July 26, 2024
An imprint-based approach to replicate nano- to microscale roughness on gelatin hydrogel scaffolds: surface characterization and effect on endothelialization.
Journal: Journal of biomaterials science. Polymer edition
Published: March 03, 2024
Learning collective cell migratory dynamics from a static snapshot with graph neural networks.
Journal: ArXiv
Published: February 12, 2024
Regulation of the DLC3 tumor suppressor by a novel phosphoswitch.
Journal: iScience
Published: October 17, 2023
Last Updated: 09/26/2026